SCHEMBL18540802

SCHEMBL18540802

COc1cccc2c(NC(C)C)cccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.49
CDC25B P30305 3/20 0.43
LPAR1 Q92633 1/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
HIF1A Q16665 1/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KRAS P01116 1/20 0.40
SOS1 Q07889 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
POLB P06746 1/20 0.39
EP300 Q09472 1/20 0.39
KAT8 Q9H7Z6 1/20 0.39
HTR1A P08908 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9162775 0.84 IDO1 (0.63) IDO1MEN1MAPTKMT2ALMNA
Hydrochloric Acid SCHEMBL11523814 0.82 IDO1 (0.42) IDO1CDC25BMEN1MAPTHTT
SCHEMBL28602988 0.80 CDC25B (0.50) CDC25BLPAR1MEN1MAPTKMT2A
SCHEMBL1644887 0.80 ALDH1A1 (0.50) LPAR1MAPTHTTKMT2ALMNA
SCHEMBL8551899 0.79 NPC1 (0.47) MEN1KMT2ALMNASMN1; SMN2POLB
SCHEMBL2995968 0.79 CDC25B (0.46) IDO1CDC25BMAPTPOLBEP300
SCHEMBL12730445 0.78 ALDH1A1 (0.42) LPAR1MAPTKMT2ALMNASMN1; SMN2
SCHEMBL20278436 0.77 IDO1 (0.47) IDO1CDC25BMEN1MAPTKMT2A
SCHEMBL31116611 0.77 CA1 (0.61) IDO1MEN1MAPTHTTKMT2A
SCHEMBL357145 0.77 CA1 (0.61) IDO1MEN1MAPTHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078214-B2 Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2021-08-03 US disclosed
US-10457688-B2 Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2019-10-29 US disclosed
US-9994586-B2 Monocyclic, thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of the same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2018-06-12 US disclosed
US-9994586-B2 Monocyclic, thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of the same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2018-06-12 US disclosed
US-20170050978-A1 Monocyclic, Thieno, Pyrido, and Pyrrolo Pyrimidine Compounds and Methods of Use and Manufacture of the Same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT 2017-02-23 US disclosed
US-20170050978-A1 Monocyclic, Thieno, Pyrido, and Pyrrolo Pyrimidine Compounds and Methods of Use and Manufacture of the Same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078214-B2 Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same DPYD, TYMS, THPO IDO1 1580/4885CDC25B 341/4885LPAR1 4123/4885
US-10457688-B2 Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same DPYD, TPX2, TYMS IDO1 1194/4885CDC25B 430/4885LPAR1 4519/4885
US-20170050978-A1 Monocyclic, Thieno, Pyrido, and Pyrrolo Pyrimidine Compounds and Methods of Use and Manufacture of the Same CYP4F3, TYMS, DPYD IDO1 765/4885CDC25B 2063/4885LPAR1 4822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.